Sr. Commercial Attorney, Transactions

About Summit: Summit Therapeutics Inc. is a biopharmaceutical oncology company with a mission focused on improving quality of life, increasing potential duration of life, and resolving serious unmet medical needs. At Summit, we believe in building a team of world class professionals who are passionate about this mission, and it is our people who drive this mission to reality. Summit’s core values include integrity, passion for excellence, purposeful urgency, collaboration, and our commitment to people. Our employees are truly the heart and soul of our culture, and they are invaluable in shaping our journey toward excellence. Summit’s team is inspired to touch and help change lives through Summit’s clinical studies in the field of oncology. Summit has multiple global Phase 3 clinical studies, including: Non-small Cell Lung Cancer (NSCLC) HARMONi: Phase 3 clinical study which was intended to evaluate ivonescimab combined with chemotherapy compared to placebo plus chemotherapy in patients with EGFR-mutated, locally advanced or metastatic non-squamous NSCLC who were previously treated with a 3rd generation EGFR TKI. HARMONi-3: Phase 3 clinical study which is intended to evaluate ivonescimab combined with chemotherapy compared to pembrolizumab combined with chemotherapy in patients with first-line metastatic NSCLC. HARMONi-7: Phase 3 clinical study which is intended to evaluate ivonescimab monotherapy compared to pembrolizumab monotherapy in patients with first-line metastatic NSCLC. Colorectal Cancer (CRC) HARMONi-GI3: Phase 3 clinical study intended to evaluate ivonescimab in combination with chemotherapy compared with bevacizumab plus chemotherapy. Ivonescimab is an investigational therapy not presently approved by any regulatory authority other than China’s National Medical Products Administration (NMPA). Summit is headquartered in Miami, Florida, and has additional offices in California, New Jersey, the UK, and Ireland. Overview of Role: The Sr. Commercial Attorney, Transactions for Summit Therapeutics (the “Company”) will be integral to supporting the successful commercial/product launch of Ivonescimab. This position reports directly to the Chief Legal Officer and serves as the primary legal liaison for the review, negotiation and drafting of all Company commercial, marketing, and market access related agreements. This role requires in-depth knowledge of pharmaceutical industry regulations and the ability to advise on commercialization, market and distribution strategies. Role and Responsibilities : Lead the drafting and negotiation of the agreements associated with the Company’s commercial activities, including but not limited to, product launches, promotional/and marketing materials, sales activities, advisory boards, speaker bureaus, patient assistance programs, patient advocacy groups, sponsorships, charitable contributions, and similar activities Draft and negotiate pricing, distribution (3PL, specialty distributors, specialty pharmacy providers, GPOs, PSPs), payer, and reimbursement agreements, including value-based and outcomes-based contracts, Including defining service levels for cold chain management and temperature sensitive biologics Support government program contracting, including Medicare, Medicaid, 340B, and VHCA Review, negotiate and draft general Master Services Agreements, Statements of Work/Purchase Orders, Amendments for the Commercial, Marketing, Market Access, and G&A functions Develop template agreements that support the Company’s commercial activities Advise on the legal structure of limited distribution networks for specialty drugs, including exclusive provider arrangements with payors or pharmacy benefit manager (PBMs.) Ensure all distribution practices adhere to federal and state laws, including the Drug Supply Chain Security Act (DSCSA), FDA regulations and Good Distribution Practice (GDP) standards Partner with commercial teams to navigate complex reimbursement, prior authorization support and c…